Cite
HARVARD Citation
Kleophas, W. et al. (n.d.). P1136STUDY DESIGN OF ELIXIR, A MULTICENTER EUROPEAN PHASE III CLINICAL TRIAL AIMED TO TEST A GLUCOSE-SPARING PD SOLUTION WHERE GLUCOSE IS MOSTLY REPLACED WITH OSMO-METABOLIC AGENTS. Nephrology dialysis transplantation. p. . [Online].